Mira Pharmaceuticals (MIRA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.63, -3.91% vs the prior close of $0.66.
- Volume 123.14K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MIRA slides 3.9% to $0.63, a 1-month low. Closed at $0.63, -3.91% vs the prior close of $0.66. Day range $0.63–$0.68, opened at $0.68.
MIRA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MIRA slides 3.9% to $0.63, a 1-month low
- Closed at $0.63, -3.91% vs the prior close of $0.66. Day range $0.63–$0.68, opened at $0.68.
- Volume was 123.14K shares, 0.2x its 50-day average of 720.22K — lighter than usual.
- Price is -17.8% vs its 50-day average ($0.77) and -37.3% vs its 200-day average ($1.01).
- 52-week range $0.60–$2.45; today's close sits at 2% of that range, 74.2% below the 52-week high.
Oct 15, 2026 — MIRA slides 3.5% to $0.66, a 1-month low
- Closed at $0.66, -3.52% vs the prior close of $0.68. Day range $0.63–$0.68, opened at $0.63.
- Volume was 128.60K shares, 0.2x its 50-day average of 719.04K — lighter than usual.
- Price is -14.6% vs its 50-day average ($0.77) and -35.0% vs its 200-day average ($1.01).
- 52-week range $0.60–$2.45; today's close sits at 3% of that range, 73.1% below the 52-week high.
Oct 14, 2026 — MIRA rises 2.4% to $0.68
- Closed at $0.68, +2.40% vs the prior close of $0.67. Day range $0.66–$0.69, opened at $0.67.
- Volume was 75.90K shares, 0.1x its 50-day average of 724.57K — lighter than usual.
- Price is -11.5% vs its 50-day average ($0.77) and -32.9% vs its 200-day average ($1.02).
- 52-week range $0.60–$2.45; today's close sits at 4% of that range, 72.2% below the 52-week high.
Oct 13, 2026 — MIRA slides 5.5% to $0.67, a 1-month low
- Closed at $0.67, -5.53% vs the prior close of $0.70. Day range $0.66–$0.70, opened at $0.70.
- Volume was 67.70K shares, 0.1x its 50-day average of 731.70K — lighter than usual.
- Price is -13.5% vs its 50-day average ($0.77) and -34.8% vs its 200-day average ($1.02).
- 52-week range $0.60–$2.45; today's close sits at 4% of that range, 72.8% below the 52-week high.
Oct 12, 2026 — MIRA slides 5.5% to $0.70
- Closed at $0.70, -5.50% vs the prior close of $0.75. Day range $0.69–$0.76, opened at $0.76.
- Volume was 90.00K shares, 0.1x its 50-day average of 731.65K — lighter than usual.
- Price is -8.3% vs its 50-day average ($0.77) and -31.3% vs its 200-day average ($1.03).
- 52-week range $0.60–$2.45; today's close sits at 6% of that range, 71.2% below the 52-week high.
Oct 9, 2026 — MIRA jumps 6.1% to $0.75
- Closed at $0.75, +6.12% vs the prior close of $0.70. Day range $0.70–$0.75, opened at $0.72.
- Volume was 52.40K shares, 0.1x its 50-day average of 731.97K — lighter than usual.
- Price is -3.2% vs its 50-day average ($0.77) and -27.6% vs its 200-day average ($1.03).
- 52-week range $0.60–$2.45; today's close sits at 8% of that range, 69.6% below the 52-week high.
Oct 8, 2026 — MIRA dips 1.0% to $0.70, a 1-month low, 3 down days in a row
- Closed at $0.70, -0.99% vs the prior close of $0.71. Day range $0.68–$0.71, opened at $0.71.
- Volume was 142.50K shares, 0.2x its 50-day average of 730.11K — lighter than usual.
- Price is -9.0% vs its 50-day average ($0.77) and -32.0% vs its 200-day average ($1.03).
- 52-week range $0.60–$2.45; today's close sits at 6% of that range, 71.3% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — MIRA ends flat (-0.3%) to $0.71, a 1-month low
- Closed at $0.71, -0.28% vs the prior close of $0.71. Day range $0.70–$0.74, opened at $0.72.
- Volume was 67.70K shares, 0.1x its 50-day average of 729.51K — lighter than usual.
- Price is -8.4% vs its 50-day average ($0.78) and -31.7% vs its 200-day average ($1.04).
- 52-week range $0.60–$2.45; today's close sits at 6% of that range, 71.0% below the 52-week high.
Oct 6, 2026 — MIRA slides 3.3% to $0.71, a 1-month low
- Closed at $0.71, -3.26% vs the prior close of $0.74. Day range $0.70–$0.76, opened at $0.76.
- Volume was 105.70K shares, 0.1x its 50-day average of 727.93K — lighter than usual.
- Price is -8.5% vs its 50-day average ($0.78) and -31.8% vs its 200-day average ($1.04).
- 52-week range $0.60–$2.45; today's close sits at 6% of that range, 70.9% below the 52-week high.
Oct 5, 2026 — MIRA rises 0.8% to $0.74
- Closed at $0.74, +0.82% vs the prior close of $0.73. Day range $0.71–$0.75, opened at $0.73.
- Volume was 86.40K shares, 0.1x its 50-day average of 727.98K — lighter than usual.
- Price is -5.8% vs its 50-day average ($0.78) and -29.7% vs its 200-day average ($1.05).
- 52-week range $0.60–$2.45; today's close sits at 7% of that range, 70.0% below the 52-week high.
Oct 2, 2026 — MIRA rises 1.0% to $0.73
- Closed at $0.73, +0.97% vs the prior close of $0.72. Day range $0.71–$0.76, opened at $0.73.
- Volume was 158.00K shares, 0.2x its 50-day average of 726.59K — lighter than usual.
- Price is -6.9% vs its 50-day average ($0.78) and -30.5% vs its 200-day average ($1.05).
- 52-week range $0.60–$2.45; today's close sits at 7% of that range, 70.2% below the 52-week high.
MIRA latest news & SEC filings
Every SEC filing by or about MIRA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Sep 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$1.21M (prior year -$1.54M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.03 (prior year -$0.09) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 31, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Jul 28, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Jul 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade MIRA
- How much it moves: over the last 20 sessions the average daily move was 3.89% (largest 14.4%). That is a volatile stock.
- Liquidity: about 137.39K shares (≈$86.87K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.63 vs a range of $0.60–$2.45 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 4 sales; latest: Erez Aminov sold 613,595 shares on Oct 16, 2025.
- Latest filings: 8-K Sep 17, 2026; 8-K Sep 16, 2026; 8-K Sep 1, 2026.
- Share count: 42.02M shares outstanding (Aug 10, 2026), +120.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
MIRA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.68 | 0.68 | 0.63 | 0.63 | 123.14K |
| Oct 15, 2026 | 0.63 | 0.68 | 0.63 | 0.66 | 128.60K |
| Oct 14, 2026 | 0.67 | 0.69 | 0.66 | 0.68 | 75.90K |
| Oct 13, 2026 | 0.70 | 0.70 | 0.66 | 0.67 | 67.70K |
| Oct 12, 2026 | 0.76 | 0.76 | 0.69 | 0.70 | 90.00K |
| Oct 9, 2026 | 0.72 | 0.75 | 0.70 | 0.75 | 52.40K |
| Oct 8, 2026 | 0.71 | 0.71 | 0.68 | 0.70 | 142.50K |
| Oct 7, 2026 | 0.72 | 0.74 | 0.70 | 0.71 | 67.70K |
| Oct 6, 2026 | 0.76 | 0.76 | 0.70 | 0.71 | 105.70K |
| Oct 5, 2026 | 0.73 | 0.75 | 0.71 | 0.74 | 86.40K |
| Oct 2, 2026 | 0.73 | 0.76 | 0.71 | 0.73 | 158.00K |
| Oct 1, 2026 | 0.84 | 0.85 | 0.62 | 0.72 | 667.70K |
| Sep 30, 2026 | 0.86 | 0.87 | 0.82 | 0.85 | 72.10K |
| Sep 29, 2026 | 0.87 | 0.90 | 0.87 | 0.87 | 61.40K |
| Sep 28, 2026 | 0.90 | 0.91 | 0.88 | 0.90 | 65.80K |
| Sep 25, 2026 | 0.86 | 0.90 | 0.85 | 0.90 | 94.70K |
| Sep 24, 2026 | 0.86 | 0.86 | 0.83 | 0.84 | 54.10K |
| Sep 23, 2026 | 0.94 | 0.94 | 0.85 | 0.86 | 118.60K |
| Sep 22, 2026 | 0.87 | 0.92 | 0.85 | 0.91 | 127.80K |
| Sep 21, 2026 | 0.82 | 0.90 | 0.80 | 0.88 | 387.60K |
About Mira Pharmaceuticals
Mira Pharmaceuticals (MIRA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in MIAMI, FL. State of incorporation: FL. Fiscal year ends —. SEC CIK 1904286.
MIRA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Erez Aminov | Chief Executive Officer | Apr 1, 2026 |
| Giudice Matthew Paul Del | Director | Jun 15, 2026 |
| Edward Clouston Macpherson | Director | Jun 15, 2026 |
| Denil Nanji Shekhat | Director | Jun 15, 2026 |
| Matthew Pratt Whalen | Director | Jun 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Erez Aminov | Chief Executive Officer | Apr 1, 2026 |
| Andriy Mushak | Chief Financial Officer | Jun 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Oct 16, 2025 | Erez Aminov | Sale | 613,595 | $2.11 |
| Oct 16, 2025 | Erez Aminov | Sale | 613,595 | $2.11 |
| Oct 16, 2025 | Erez Aminov | Sale | 613,595 | $2.11 |
| Oct 16, 2025 | Erez Aminov | Sale | 613,595 | $2.11 |
MIRA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-10.44M | -1.35 | $-4.66M |
| Dec 31, 2024 | — | $-7.85M | -0.51 | $-5.56M |
| Dec 31, 2023 | — | $-11.98M | -0.85 | $-4.53M |
| Dec 31, 2022 | — | $-7.06M | -0.40 | $-5.60M |
Latest balance sheet: total assets $8.20M, total liabilities $40.82K, cash $3.61M (as of Jun 30, 2026).
MIRA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MIRA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.